No credit card. No commitment.
5000+ G2 reviews
Samsung Bioepis
Pharmaceuticals
Founded in 2012
IncheonSamsung Bioepis
PharmaceuticalsFounded in 2012Incheon
EmployeesSamsung Bioepis' financial review
Samsung Bioepis' Revenue (Yearly)
859M
Employees
760
Total Funding
667M
Last Funding Round
667M
Samsung Bioepis information
Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that cover a spectrum of therape...
Established in 2012, Samsung Bioepis is a biopharmaceutical company committed to realizing healthcare that is accessible to everyone. Through innovations in product development and a firm commitment to quality, Samsung Bioepis aims to become the world's leading biopharmaceutical company. Samsung Bioepis continues to advance a broad pipeline of biosimilar candidates that cover a spectrum of therapeutic areas, including immunology, oncology and ophthalmology. For more information, please visit: www.samsungbioepis.com.To see our community guidelines, please visit: bit.ly/2l0yiI3
Samsung Bioepis industries
Biosimilars
Pharmaceutical
Biopharmaceutical
Biotechnology
Samsung Bioepis' financial review
Samsung Bioepis' Revenue (Yearly)
859M
Employees
760
Total Funding
667M
Last Funding Round
667M
Employee Metrics
Technologies
Other
Hosting
Other
Load Balancers
Tag Management
Other
Notable Alumni
Employees
Prospect on LinkedIn
Find verified emails and direct dial mobile numbers of contacts on LinkedIn, and sync them with your CRM instantly
Download Extension
Why our clients choose Apollo
“Apollo completely changed the game for us. It allowed us to identify relevant targets that are ready to scale and reach out to them at the exact right time.”
Erik Straub
Head of Product, Kickfurther
“Using Apollo.io, we've solved the biggest problem for every business, the lead problem. We are now constrained by sales time and no longer lack interested prospects.”
Michael Transon
CEO, Victorious
